DE3674955D1 - Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten. - Google Patents

Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten.

Info

Publication number
DE3674955D1
DE3674955D1 DE8686201213T DE3674955T DE3674955D1 DE 3674955 D1 DE3674955 D1 DE 3674955D1 DE 8686201213 T DE8686201213 T DE 8686201213T DE 3674955 T DE3674955 T DE 3674955T DE 3674955 D1 DE3674955 D1 DE 3674955D1
Authority
DE
Germany
Prior art keywords
protein
preparing
pharmaceutical compositions
compositions containing
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686201213T
Other languages
English (en)
Inventor
Cornelis Kluft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Original Assignee
Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO filed Critical Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek TNO
Application granted granted Critical
Publication of DE3674955D1 publication Critical patent/DE3674955D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE8686201213T 1985-07-12 1986-07-10 Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten. Expired - Fee Related DE3674955D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8502017A NL8502017A (nl) 1985-07-12 1985-07-12 Nieuw, in het bloed geidentificeerd eiwit, werkwijze ter bereiding daarvan, werkwijze ter bepaling van dit eiwit en tevens van t-pa-remmer, en farmaceutische preparaten die het eiwit bevatten.

Publications (1)

Publication Number Publication Date
DE3674955D1 true DE3674955D1 (de) 1990-11-22

Family

ID=19846293

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686201213T Expired - Fee Related DE3674955D1 (de) 1985-07-12 1986-07-10 Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten.

Country Status (6)

Country Link
US (1) US5004802A (de)
EP (1) EP0208383B1 (de)
JP (1) JP2512437B2 (de)
AT (1) ATE57471T1 (de)
DE (1) DE3674955D1 (de)
NL (1) NL8502017A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372719A (en) * 1992-03-30 1994-12-13 Perseptive Biosystems, Inc. Molecular imaging
US5474766A (en) * 1992-12-18 1995-12-12 Washington University Methods and compositions for inhibition of hepatic clearance of tissue-type plasminogen activator
US5607841A (en) * 1994-06-20 1997-03-04 Lipinski; Boguslaw Preparation and proteolytic degradation of a macromolecular protein complex from fibrinogen
CN105517565A (zh) 2013-01-22 2016-04-20 田纳西大学研究基金会 组织纤溶酶原激活物抗体及其用途

Also Published As

Publication number Publication date
EP0208383B1 (de) 1990-10-17
US5004802A (en) 1991-04-02
JPS6277326A (ja) 1987-04-09
NL8502017A (nl) 1987-02-02
JP2512437B2 (ja) 1996-07-03
EP0208383A1 (de) 1987-01-14
ATE57471T1 (de) 1990-11-15

Similar Documents

Publication Publication Date Title
Kitani et al. Purification and some properties of a protein inhibitor (antizyme) of ornithine decarboxylase from rat liver.
Nielsen et al. Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody
Dixit et al. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin.
Ogawa et al. Human epidermal transglutaminase. Preparation and properties.
Kagan et al. Purification and properties of four species of lysyl oxidase from bovine aorta
Summaria et al. Isolation and characterization of the affinity chromatography forms of human Glu-and Lys-plasminogens and plasmins.
Ohlsson et al. Demonstration and semiquantitative determination of complexes between various proteases and human α2-macroglobulin
Silverstein et al. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
Kohno et al. Kidney plasminogen activator: a precursor form of human urokinase with high fibrin affinity
CA1267497C (en) PROTEIN RECOVERY
Deogny et al. Improved fibrin plate method for fibrinolytic activity measurements: use of bentonite precipitation and agar solidification
Sia et al. Studies on the subunit structure of rabbit liver fructose diphosphatase
Filpula et al. DNA polymerase-alpha. Common polypeptide core structure of three enzyme forms from human KB cells.
Nissen et al. Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease.
DE3674955D1 (de) Im blut identifiziertes protein, ein verfahren zu seiner zubereitung, ein verfahren fuer die bestimmung dieses proteins und ebenfalls des t-pa-hemmungsfaktors und pharmazeutische zusammensetzungen, die dieses protein enthalten.
Livingstone et al. The purification and preliminary characterization of UMP synthase from human placenta.
Wicher et al. Interactions of Bacillus subtilis alkaline proteinases with α2-macroglobulin and α1-antitrypsin
Lundblad et al. The covalent differences between bovine alpha-and beta-thrombin. A structural explanation for the changes in catalytic activity.
Markland et al. Resolution of isoforms of natural and recombinant fibrinolytic snake venom enzyme using high performance capillary electrophoresis
Robinson et al. Trypsins In Human Pancreatic Juice–Their Distribution as Found in 34 Specimens. Two Human Pancreatic Trypsinogens
Gache et al. Susceptibility of platelet α-actinin to a Ca2+-activated neutral protease
Song et al. Large scale purification of α2-macroglobulin from human plasma
Plishker et al. Human epidermal transglutaminase: stimulation by trypsin, organic solvents, and chaotropic salts
Müllertz et al. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee